EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer

Yunyan Zhang iD, Zhuolin Liu iD, Liu Yu, Aoyu Fan, Yunpeng Li, Xiaobo Li, Wei Chen iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yunyan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Computational Biology, Disease Progression, Prostatic Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa), a prevalent malignancy among elderly males, exhibits a notable rate of advancement, even when subjected to conventional androgen deprivation therapy or chemotherapy. An effective progression prediction model would prove invaluable in identifying patients with a higher progression risk. Using bioinformatics strategies, we integrated diverse data sets of PCa to construct a novel risk model predicated on gene expression and progression‐free survival (PFS). The accuracy of the model was assessed through validation using an independent data set. Eight genes were discerned as independent prognostic factors and included in the prediction model. Patients assigned to the high‐risk cohort demonstrated a diminished PFS, and the areas under the curve of our model in the validation set for 1‐year, 3‐year, and 5‐year PFS were 0.9325, 0.9041 and 0.9070, respectively. Additionally, through the application of single‐cell RNA sequencing to two castration‐related prostate cancer (CRPC) samples and two hormone‐related prostate cancer (HSPC) samples, we discovered that luminal cells within CRPC exhibited an elevated risk score. Subsequent molecular biology experiments corroborated our findings, illustrating heightened SYK expression levels within tumour tissues and its contribution to cancer cell migration. We found that the knockdown of SYK could inhibit migration in PCa cells. Our progression‐related risk model demonstrated the potential prognostic value of SYK and indicated its potential as a target for future diagnosis and treatment strategies in PCa management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computational BiologyDisease ProgressionProstatic NeoplasmsGene Expression Regulation, NeoplasticMaleHumansPrognosisGene Expression ProfilingBiomarkers, TumorRisk FactorsCell Line, Tumor

Stichwörter der Autor:innen

SYKprogression‐related genesprostate cancersingle‐cell RNA‐seq analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • School of Basic Medical Sciences, Fudan University, Shanghai, China.

ORCID-Profile: Yunyan Zhang, Zhuolin Liu, Wei Chen

Zitieren

APA

Zhang, Y., Liu, Z., Yu, L., Fan, A., Li, Y., Li, X., & Chen, W. (2024). Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18405

Vancouver

Zhang Y, Liu Z, Yu L, Fan A, Li Y, Li X, et al. Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18405

BibTeX
@article{Zhang2024,
  author = {Zhang, Yunyan and Liu, Zhuolin and Yu, Liu and Fan, Aoyu and Li, Yunpeng and Li, Xiaobo and Chen, Wei},
  title = {Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18405}
}
Kostenlos starten →